Home / Featured Companies / Amgen Historical Data

Amgen (AMGN) Financials

Amgen (AMGN) Historical Financial Statements and Key Metrics for 1986 - 2021

Full Amgen financials for 1986 - 2021 are available in the US Historical Financials dataset.

All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.

Amgen Income Statements
(in $ 000,000's)
Quarter End Revenue Gross Profit Operating Income Net Income EBITDA EPS
2021-Mar-31 5,901 4,411 (74.8 %) 2,129 (36.1 %) 1,646 (27.9 %) 2,970 2.83
2020-Dec-31 6,634 5,037 (75.9 %) 2,008 (30.3 %) 1,615 (24.3 %) 2,881 2.76
2020-Sep-30 6,423 4,862 (75.7 %) 2,453 (38.2 %) 2,021 (31.5 %) 3,354 3.43
2020-Jun-30 6,206 4,718 (76.0 %) 2,323 (37.4 %) 1,803 (29.1 %) 3,253 3.05
2020-Mar-31 6,161 4,648 (75.4 %) 2,355 (38.2 %) 1,825 (29.6 %) 3,252 3.07
2019-Dec-31 6,197 4,944 (79.8 %) 2,048 (33.0 %) 1,703 (27.5 %) 2,750 2.85
2019-Sep-30 5,737 4,701 (81.9 %) 2,476 (43.2 %) 1,968 (34.3 %) 2,984 3.27
Full historical income statements for 1986 - 2021 is included in the US Historical Financials dataset.

Amgen Balance Sheets
(in $ 000,000's)
Quarter End Total Assets Total Liabilities Total Debt Total Equity Cash & Equivalents
2021-Mar-31 62,539 53,205 32,685 9,334 10,566
2020-Dec-31 62,948 53,539 32,986 9,409 10,647
2020-Sep-30 64,637 53,678 34,287 10,959 12,360
2020-Jun-30 65,011 54,352 34,224 10,659 11,421
2020-Mar-31 61,669 52,184 31,848 9,485 8,012
2019-Dec-31 59,707 50,034 29,903 9,673 8,911
2019-Sep-30 59,535 48,608 29,791 10,927 20,853
Full historical balance sheet data for 1986 - 2021 is included in the US Historical Financials dataset.

Amgen Cash Flow Statements
(in $ 000,000's)
Quarter End Operating Cash Flow Investing Financing Free Cash Flow
2021-Mar-31 2,104 -319 -1,939 1,938
2020-Dec-31 2,153 -1,384 -3,590 1,980
2020-Sep-30 3,368 -1,628 -1,798 3,233
2020-Jun-30 2,842 -2,159 775 2,684
2020-Mar-31 2,134 -230 -254 1,992
2019-Dec-31 2,514 -5,963 -1,929 2,326
2019-Sep-30 3,377 5,372 -2,859 3,207
Full historical cash flow data for 1986 - 2021 is included in the US Historical Financials dataset.

Amgen Key Valuation and Operating Metrics
Quarter End Market Capitalization
($ 000,000's)
Enterprise Value
($ 000,000's)
Price/Earnings
($ 000,000's)
Price/Sales
($ 000,000's)
Price/Book
($ 000,000's)
2021-Mar-31 143,563 170,136 24.33 21.80 15.38
2020-Dec-31 134,503 161,223 20.27 20.82 14.30
2020-Sep-30 148,684 173,884 23.15 18.39 13.57
2020-Jun-30 138,686 163,765 22.35 19.23 13.01
2020-Mar-31 119,611 143,772 19.41 16.39 12.61
2019-Dec-31 142,955 166,821 23.07 20.99 14.78
2019-Sep-30 115,912 134,288 20.20 14.72 10.61
Full historical valuation and operating metrics for 1986 - 2021 are included in the US Historical Financials dataset.